Home Blog Page 147

Semaglutide Patent Expiry Triggers Generic Rush in India

0

A major shift is underway in the global diabetes and obesity treatment market as the patent for Semaglutide expires in key markets, including India. The development opens the door for a wave of lower-cost alternatives to blockbuster drugs like Wegovy and Ozempic from Novo Nordisk. As a result, the market is poised for intense competition, with multiple pharmaceutical companies preparing to launch generic versions immediately after the patent expiry on March 20.

Multiple Generic Launches Expected

Industry insiders estimate that 15 to 50 branded generic versions could enter the market. These products are expected to be priced significantly lower than the innovator drugs, making treatment more accessible. At the same time, pharmaceutical companies have already formed strategic partnerships to strengthen market reach.  Additionally, companies such as Dr. Reddy’s Laboratories, Sun Pharma, Glenmark Pharmaceuticals, MSN Laboratories, Mankind Pharma, and Alkem Laboratories are also gearing up to enter the segment.

Significant Price Reduction Expected

The entry of generics is likely to disrupt pricing dynamics. Industry estimates suggest that generic versions could be priced 60% lower than innovator products, or even at one-third to one-fifth of the original cost. Consequently, this price drop could expand access to advanced obesity and diabetes treatments across a broader patient base.

Experts Urge Caution on Safety and Use

Despite the optimism, experts have raised concerns about potential risks associated with widespread use of injectable semaglutide. Recently, authorities have cautioned against surrogate advertising of these prescription drugs under the guise of awareness campaigns. There are also concerns about adverse effects, including complications such as pancreatitis.

Sheetal Sapale, Vice-President (Commercial), Pharmarack Technologies, noted that companies are launching multiple brands similar to the innovator products. However, only a limited number of generics currently have regulatory approval in India. She added that companies may differentiate their offerings through innovations such as improved drug delivery devices.

Regulatory Scrutiny and Industry Concerns

Jitendra Chouksey, Founder and CEO of Fittr, has raised concerns about the transparency of the approval process. He had earlier approached the Delhi High Court, seeking greater regulatory oversight. Chouksey warned that increased usage could lead to a rise in hospitalisations and side effects, urging stricter accountability within the healthcare system.

Innovator Responds with Price Cuts and Partnerships

In anticipation of rising competition, Novo Nordisk has already taken proactive steps. The company launched Wegovy in India in June 2025 as a once-weekly injection available in multiple dose strengths. Subsequently, it reduced prices by up to 37% on its starting dose in November. Additionally, Novo partnered with Emcure to introduce another semaglutide brand, while Abbott is preparing to launch its own version in India.

Competitive Landscape Expands in Obesity Segment

The obesity drug market is also heating up with competition from Eli Lilly. Its product Mounjaro (tirzepatide) entered the Indian market earlier and has gained traction. Later, Eli Lilly partnered with Cipla to market the drug under a different brand name at the same price. Notably, Mounjaro has already achieved ₹100 crore in sales in recent months.

Understanding GLP-1 Drugs

Both semaglutide and tirzepatide belong to the GLP-1 receptor agonist class of drugs. These therapies mimic the natural GLP-1 hormone, which helps regulate blood sugar levels by increasing insulin production in response to food intake. As demand for effective obesity and diabetes treatments grows, this class of drugs is expected to play a transformative role in the healthcare landscape.

Outlook: Accessibility vs. Accountability

As reported by thehindubusinessline.com, the expiry of the semaglutide patent marks a turning point for the pharmaceutical industry. While lower-cost generics promise wider accessibility, they also bring challenges around regulation, safety, and responsible usage. Balancing affordability with patient safety will be critical as the next phase of growth unfolds in this high-demand therapeutic segment.

India Adopts Multi-Pronged Strategy to Secure Fertiliser Supply Amid West Asia Conflict

0

Amid disruptions in gas and fertiliser supplies triggered by the ongoing conflict in West Asia, the Government has rolled out a comprehensive strategy to stabilise availability ahead of the Kharif 2026 sowing season, which begins with the monsoon around June 1. The approach focuses on boosting domestic urea production while simultaneously strengthening fertiliser imports to shield farmers from global supply shocks.

Protecting Farmers from Supply Volatility

According to the Department of Fertilizers, the government has combined production increases with a well-planned global procurement strategy. As a result, it aims to insulate Indian farmers from ongoing supply chain disruptions. Randhir Jaiswal, spokesperson for the Ministry of External Affairs, assured that fertiliser stocks remain adequate for the upcoming season. He added that global tenders were floated well in advance, receiving strong responses from multiple suppliers. Most of the ordered quantities are expected to arrive by the end of March, supported by a diversified sourcing strategy involving multiple countries.

Gas Supply Prioritised for Urea Plants

To address reduced capacity utilisation caused by limited LNG availability, the government has taken swift action. It has prioritised gas supply to urea plants under Priority II, following essential domestic LPG requirements. Additionally, authorities have committed to supplying 70% of the average gas requirement (based on the past six months) to these plants. This move ensures continuity in production despite global disruptions.

Increased LNG Procurement Boosts Supply

In a significant development, the government has secured 7.31 million metric standard cubic meters per day (mmscmd) of LNG from the spot market. This procurement will increase gas supply to urea plants by 23%, raising total availability from 32 mmscmd to 39.31 mmscmd. As a result, plants will now meet approximately 76% of their average gas demand, compared to 62% earlier. Although the spot LNG price is estimated at around $18/MMBtu, higher than long-term contract rates, the move ensures uninterrupted production.

Domestic Urea Output Set to Rise Sharply

With these interventions, domestic urea production is expected to increase significantly. The government projects output to rise by nearly 23%, from 54,500 tons/day to 67,000 tons/day. For instance, IFFCO has already achieved 100% capacity utilisation in three of its five plants, supported by improved gas allocation. The remaining plants are currently under maintenance, allowing gas diversion to operational units.

Global Sourcing and Import Strategy

To further strengthen supply, India is actively engaging with global suppliers, including Russia, Belarus, Morocco, and Canada. At present, the government is prioritising urea imports. However, it may expand procurement of DAP, TSP, and MOP depending on how the situation evolves over the next few weeks. Additionally, smaller volumes may be imported through negotiated deals to address immediate needs.

Outlook: Preparedness Key for Kharif Season

Overall, India’s proactive and diversified approach—combining domestic production boosts, strategic LNG procurement, and global sourcing—positions it well to manage fertiliser supply challenges. As reported by thehindubusinessline.com, if the geopolitical situation stabilises soon, supply chains could normalise quickly. However, the government’s preparedness ensures that farmers remain protected even if disruptions persist.

Geopolitical Strain in West Asia Pushes Polymer Prices Upward

0

Plastic product prices across multiple sectors are likely to increase from April as supply constraints of key raw materials persist amid the ongoing conflict in West Asia. The situation has disrupted supply chains, pushing input costs higher and placing significant pressure on the plastics industry.

Sharp Rise in Polymer Prices Strains Industry

In recent days, prices of polymers—primarily derived from crude oil and natural gas—have surged sharply. As a result, the plastics industry is grappling with rising costs and supply uncertainties. According to Arvind M Mehta, Chairman of the All India Plastics Manufacturers Association, polymer prices have already increased by 50–60%. While prices are expected to stabilise at current levels, the industry remains cautious about further volatility. He noted that manufacturers currently hold inventory for 15–20 days. Consequently, companies have begun passing on incremental cost increases to consumers through marginal price hikes. However, he warned that a prolonged conflict could intensify the crisis.

Supply Disruptions May Have Lasting Impact

Highlighting the uncertainty, Mehta added that many manufacturers are now accepting fresh orders only from corporate clients willing to accommodate price revisions. Furthermore, even if the conflict subsides by the end of March and supply chains normalise, its impact could linger for at least 45 days, affecting pricing and availability across the value chain.

Industry Seeks Government Support

Amid rising pressures, industry leaders are urging the government to introduce relief measures. Sunil Shah, President of AIPMA, stated that the association has submitted key recommendations to support the sector. These include increasing working capital limits by 20%, similar to measures implemented during the COVID-19 period. Additionally, the industry has requested a reduction in GST from 18% to 10% to improve liquidity and ease financial stress.

Demand Slows Across Key Sectors

Meanwhile, rising prices have already dampened demand. Industry estimates suggest a 25–30% decline in demand, particularly in sectors such as automotive, agriculture, and packaging. If the conflict continues, this slowdown could deepen further, affecting production volumes and profitability across the plastics ecosystem.

Export Strategy Gains Momentum

To counter domestic weakness, the industry is actively exploring export opportunities. Following recent free trade agreements, manufacturers are targeting new international markets to drive growth.

Currently, the global trade in finished plastic products stands at approximately $1.3 trillion, while India’s share is just $12.5 billion, or around 1%. Notably, the United States alone imports plastic products worth over $72 billion annually, presenting a significant opportunity.

As a result, Indian exporters are now focusing on nearly 20 new markets, including Mexico, France, Brazil, Italy, the Netherlands, Japan, the UK, and Belgium. This diversification strategy gained urgency after the US imposed higher tariffs on Indian goods.

Outlook: Volatility Likely to Persist

As reported by thehindubusinessline.com, the plastics industry faces a challenging near-term outlook marked by rising input costs, supply disruptions, and weakening demand. However, a strategic push toward exports and timely policy support could help mitigate the impact and stabilise growth in the coming months.

Croda Expands India Footprint with Dahej Manufacturing Facility

0

Croda International inaugurated a new greenfield manufacturing facility in Dahej, reinforcing its commitment to India and expanding its footprint across fast-growing Asian markets. The investment marks a strategic step toward enhancing supply capabilities while supporting sustainable innovation.

Boosting Supply Capabilities and Market Reach

The newly commissioned site significantly strengthens Croda’s ability to meet rising customer demand. In particular, it improves responsiveness, enhances supply chain efficiency, and supports long-term growth in high-value segments.

Located in Gujarat, the facility benefits from strong logistics connectivity. Consequently, it is well-positioned to serve both domestic customers and select export markets. The plant will cater to key business segments, including Consumer Care, Life Sciences, and Industrial Specialties.

Built Green, Smart, and Future-Ready

Designed around the theme “Built Green. Built Smart. Built for the Future,” the Dahej facility places sustainability at its core. From the outset, Croda has integrated advanced measures to reduce environmental impact. For instance, the site is expected to significantly lower Scope 1 and Scope 2 emissions by utilizing renewable electricity and cleaner fuel sources. In addition, it will feature Zero Liquid Discharge (ZLD) systems, scheduled to become operational later this year. The facility uses RSPO-certified oleochemicals and aligns with Extended Producer Responsibility (EPR) requirements for plastic recycling. As a result, it supports both regulatory compliance and Croda’s broader sustainability goals.

Advanced Operations with Strong Safety Standards

Beyond sustainability, the plant incorporates advanced operating systems, robust quality infrastructure, and stringent safety protocols. These features ensure reliable and efficient manufacturing processes. Notably, during construction, the project achieved over 5 million safe working hours, reflecting Croda’s strong “Safety First Always” culture. This milestone underscores the company’s unwavering focus on workplace safety.

Driving Inclusion and Workforce Diversity

In addition to operational excellence, Croda is actively promoting inclusivity at the Dahej site. The facility features 100% women-led packaging operations, demonstrating a progressive approach to workforce diversity. Moreover, the company aims to achieve 30% female representation at the site, further strengthening its commitment to inclusive growth.

Leadership Perspective on Strategic Growth

Steve Foots, Group Chief Executive, emphasized that the Dahej investment highlights Croda’s
long-term commitment to India. He noted that the facility combines strong sustainability credentials with high operational and safety standards, enabling the company to better serve customers in India and global markets. He also pointed to significant long-term growth opportunities in the region. Murali Duvvuri, Senior Managing Director, Life Sciences – Asia and Region India, highlighted India’s strategic importance for Croda. He added that the new site brings the company closer to its customers while strengthening local manufacturing capabilities.

Enabling Sustainable Growth in India

As per the press release, the Dahej facility positions Croda to deliver high-quality, sustainable solutions with greater speed, flexibility, and reliability. By combining advanced manufacturing, sustainability, and inclusivity, the company is well-equipped to support customer innovation and drive future growth in India and beyond.

Honeywell Launches AI-Powered Control Room Assistant

0

Honeywell announced the commercial launch of Experion Operations Assistant, an advanced
AI-driven solution aimed at transforming how industrial operators monitor plant performance, make critical decisions, and proactively respond to alarm situations.

A Smarter Approach to Plant Operations

Built on Honeywell’s flagship distributed control system, Experion PKS, the new solution combines historical plant data with real-time operational insights. As a result, operators can anticipate potential risks linked to unsafe conditions and production losses before they escalate.

Moreover, Experion Operations Assistant bridges the gap between autonomous systems and human operators. Instead of reacting to alarms, operators can now forecast issues and take preventive action—significantly improving plant efficiency and safety.

Proven Results from Industry Pilots

The commercial rollout follows a successful pilot program involving global energy majors like Chevron and TotalEnergies. During the pilot phase, the AI-powered assistant demonstrated measurable impact by predicting potential alarm incidents 5–10 minutes in advance. Consequently, operators were able to implement timely corrective actions, minimize unplanned downtime, and prevent operational disruptions.

Addressing Industry Challenges with AI

According to Jim Masso, President and CEO of Honeywell Process Automation, industries today face mounting pressure to maximize asset productivity while managing workforce transitions. He emphasized that the solution leverages over five decades of process automation expertise, combined with site-specific data and advanced AI capabilities. Therefore, operators can detect issues earlier, respond with greater confidence, and ensure safer, more efficient operations.

Seamless Integration with Existing Systems

Importantly, Experion Operations Assistant integrates smoothly within Honeywell’s Experion PKS ecosystem. This ensures that organizations can deploy the solution without overhauling their existing control room infrastructure. In addition, the platform captures site-specific knowledge and uses advanced language models to analyze data in real time. This enables the system to proactively guide operators, offering actionable insights before problems occur.

Enabling the Future of Industrial Automation

Overall, the launch of Experion Operations Assistant marks a significant step toward intelligent, predictive operations. By combining AI with deep industrial expertise, Honeywell is enabling companies to move from reactive responses to proactive decision-making—ultimately driving safer, more resilient, and more efficient industrial environments.

India Must Invest in Indigenous Cold Chain Tech to Safeguard Supply Chains: FICCI Grant Thornton Report

0

India must accelerate the development of indigenous robotics, sensors, and artificial intelligence tools tailored to local conditions to reduce reliance on imported cold-chain technologies. This key recommendation comes from a new knowledge report released by FICCI and Grant Thornton Bharat at the third edition of the FICCI Gatishakti Summit. The report, Transforming India’s Logistics Ecosystem: Warehousing, Cold Chain and Role of Technology, highlights the urgent need for a shift from infrastructure expansion to system efficiency and technological integration.

From Capacity Creation to System Efficiency

While India has made notable progress in reducing logistics costs—from 13–14% of GDP to approximately 7.9%—the report emphasizes that the next phase of growth depends on improving system effectiveness. To achieve this, it recommends establishing a national R&D centre for cold-chain automation. Such a move would not only strengthen domestic capabilities but also reduce dependence on global technology supply chains.

Infrastructure Growth, Yet Persistent Losses

India currently operates 8,815 cold storage facilities with a combined capacity of 402.18 lakh metric tonnes. However, post-harvest losses in fruits and vegetables remain high, ranging between 6% and 15%. The report attributes these losses not just to infrastructure gaps but also to limited automation, fragmented supply-chain planning, and insufficient integration of intelligent systems across storage and transport networks. Therefore, developing indigenous technology could lower capital costs, improve energy efficiency, and enhance overall supply chain resilience.

Policy Support and Digital Integration Gains Momentum

Industry leaders and policymakers at the summit reinforced the need for innovation-led growth. Anita Praveen, Chairperson of the Warehousing Development and Regulatory Authority, highlighted India’s electronic negotiable warehousing receipt system as a key enabler for expanding storage capacity through private participation. She emphasized that farmers can leverage warehouse receipts to access financing, thereby avoiding distress sales. Moreover, she noted that India’s logistics ecosystem is at an inflection point, with infrastructure, digital tools, and policy frameworks increasingly aligned.

Logistics Infrastructure Set for Rapid Expansion

Anshuman Singh, Co-Chair of the FICCI Committee on Logistics and CEO of IndoSpace, placed the R&D push within the context of rapid infrastructure growth. India currently has around 500 million square feet of logistics parks, including 250 million square feet of Grade-A organized space. Looking ahead, this capacity is expected to double to over 1,000 million square feet in the next five years. Key drivers include initiatives such as the PM Gati Shakti, the National Logistics Policy, and the Multimodal Logistics Parks program. Additionally, the government’s ₹33,660 crore Bhavya Yojana aims to develop 100 plug-and-play logistics parks through public-private partnerships, further accelerating infrastructure development.

Integration and Efficiency: The Next Frontier

Pankaj Kumar, Joint Secretary at the Department for Promotion of Industry and Internal Trade, pointed out that while reducing logistics costs is important, efficiency must also include resilience, sustainability, and stakeholder outcomes. He stressed that integration remains a critical gap. In this context, he urged industry stakeholders to utilize the PM Gati Shakti portal as a comprehensive planning tool for integrated infrastructure, rather than viewing it merely as a GIS platform.

Last-Mile Challenges and Data-Driven Transformation

Pali Tripathi, Co-Chair of the FICCI Committee on Logistics and CEO of Taabi Mobility, identified last-mile execution as a persistent bottleneck. According to her, the sector must now focus on faster, coordinated action across the logistics ecosystem. She highlighted a crucial shift—from mere data availability to data velocity—and from isolated insights to integrated, real-time decision-making across ports, warehouses, and multimodal transport systems.

Building a Future-Ready Logistics Ecosystem

Rajat Kumar Saini, Managing Director and CEO of the National Industrial Corridor Development Corporation, emphasized that infrastructure investments must go hand-in-hand with workforce formalization, regulatory reforms, and skill development. As per the press release, the FICCI–Grant Thornton Bharat report positions indigenous cold-chain automation as essential for building a resilient, efficient, and climate-ready logistics ecosystem. This transformation will be critical for achieving India’s long-term vision of becoming a globally competitive economy under the Viksit Bharat 2047 mission.

TCS and ABB Deepen Strategic Partnership in IT, AI, and Engineering

0

Tata Consultancy Services Limited (TCS) signed a Memorandum of Understanding (MoU) with ABB to strengthen their long-standing strategic collaboration. Through this agreement, both companies aim to accelerate advancements across IT infrastructure, digital and industrial AI, data centres, and other emerging technologies. The partnership reflects a shared vision to drive innovation, enhance operational resilience, and enable sustainable growth. By adopting a long-term collaboration approach, TCS and ABB are positioning themselves to lead the next phase of industrial transformation.

Combining Strengths for Digital Transformation

As part of the MoU, the two companies will leverage their complementary strengths. ABB brings deep expertise in electrification and automation, while TCS contributes its global technology capabilities and large-scale delivery experience. Together, they will focus on building agile, secure, and resilient digital ecosystems that align with ABB’s evolving operating model. This integrated approach is expected to significantly improve operational efficiency and support continuous innovation.

Key Areas of Collaboration

IT Infrastructure and Applications Transformation: To begin with, the partnership will focus on modernizing IT infrastructure and applications. This includes developing a cost-optimized, secure, and scalable IT foundation. As a result, ABB will benefit from enhanced operational efficiency and improved system resilience.

AI and Factory Modernization: In addition, both companies will collaborate on next-generation industrial technologies. These include industrial AI, digital twins, vision-based inspection systems, and the convergence of operational technology (OT) and information technology (IT). Consequently, manufacturers can expect smarter, more automated, and data-driven operations.

AI Infrastructure Development: Furthermore, TCS and ABB will explore opportunities linked to AI infrastructure development in India. This includes initiatives in electrification, automation, digital platforms, and software solutions. Therefore, the collaboration is likely to create new growth avenues while strengthening India’s position as a technology hub.

Leadership Perspectives on the Partnership

Morten Wierod, CEO of ABB, emphasized the strategic value of the collaboration. He noted that partnering with TCS will enable ABB to build smarter systems, respond faster to market changes, and scale innovations globally. He also highlighted India as a key growth market and indicated that the partnership would support ABB’s role in TCS’ expanding data centre ecosystem.

Krithivasan, MD and CEO of TCS, underlined the broader vision behind the alliance. He stated that the partnership goes beyond incremental transformation and aims to shape the future of industrial enterprises. By combining ABB’s strengths in electrification and automation with TCS’ expertise in AI, data, and engineering, the companies plan to co-create intelligent, resilient, and future-ready solutions at scale.

Advancing AI-Led Industrial Innovation

Overall, this strengthened partnership signals a shift toward AI-driven industrial innovation. Rather than simply modernizing existing systems, TCS and ABB are working together to redefine how industrial enterprises operate. As per the press release, by integrating advanced technologies with domain expertise, the collaboration is set to deliver scalable, efficient, and sustainable solutions—ultimately creating long-term value across global operations.

India Expanded Solar Manufacturing Capacity Significantly in 2025

0

India significantly strengthened its solar manufacturing base in 2025 by adding 119 GW of solar module capacity and over 9 GW of solar cell capacity. As a result, the country’s cumulative manufacturing capacity reached approximately 210 GW for modules and 27 GW for cells. The rapid expansion underscores India’s growing ambition to become a global solar manufacturing hub.

Key Drivers Powering Growth

Several factors fuelled the surge in capacity. To begin with, a strong pipeline of utility-scale solar projects created sustained demand for modules. In addition, the government’s PM Surya Ghar initiative accelerated residential rooftop solar adoption across the country. The domestic cell manufacturing mandate under ALMM List II played a crucial role in encouraging local production. Together, these initiatives helped create a supportive ecosystem for domestic manufacturers.

Market Shifts Toward Advanced Technologies

At the same time, the solar manufacturing landscape is evolving. Demand for mono PERC technology is gradually declining, while manufacturers are increasingly investing in more advanced and efficient technologies. Consequently, rising capital requirements are shifting market share toward larger, well-capitalized players. This trend is expected to further consolidate the industry and drive technological upgrades.

Import Dependence and Export Trends

Despite the strong domestic expansion, India continues to rely heavily on imports. In 2025, the country imported nearly 99 GW of solar modules and cells, with solar cells accounting for about 75% of the total imports. On the other hand, domestic manufacturers also made progress in exports. India exported around 5 GW of solar modules, primarily to the United States, and approximately 192 MW of solar cells, with most shipments directed to the UAE.

Strengthening India’s Solar Supply Chain

As reported by news.metal.com, India’s rapid capacity addition reflects a strategic push toward self-reliance and supply chain resilience. While import dependence remains a challenge, continued policy support and investments in advanced technologies are likely to enhance domestic competitiveness in the coming years.

MNRE Expands ALMM Framework to Solar Ingots and Wafers from June 2028

0

The Ministry of New and Renewable Energy (MNRE) announced a major policy expansion with the introduction of Approved List of Models and Manufacturers (ALMM) List-III for solar ingots and wafers. The new framework will come into effect from June 1, 2028, marking a significant step toward strengthening India’s solar manufacturing ecosystem.

Extending ALMM Up the Solar Value Chain

With this move, MNRE has extended the ALMM framework beyond solar modules and cells to include upstream components such as ingots and wafers. This transition is particularly important because India currently relies heavily on imports for these critical inputs. By mandating domestic sourcing at multiple stages of the value chain, the government aims to reduce import dependency while improving supply chain resilience.

Union Minister for MNRE, Pralhad Joshi, emphasized the strategic importance of the decision, stating that the expansion will help build a self-reliant and globally competitive solar manufacturing ecosystem. He added that the move will not only boost domestic production but also enhance quality standards across the sector.

Why This Move Matters

Wafers play a critical role in the solar manufacturing process, acting as the link between polysilicon and solar cells. However, India’s domestic wafer production capacity remains limited, making the country dependent on imports. By bringing wafers and ingots under the ALMM framework, MNRE is addressing a crucial gap in the solar supply chain.

A Step Toward Solar Self-Reliance

Overall, MNRE’s decision to expand the ALMM framework represents a strategic shift toward deepening domestic capabilities in solar manufacturing. As India continues its push toward renewable energy leadership, this move is expected to play a pivotal role in building a robust, self-sufficient, and globally competitive solar industry.

Lupin and Zydus Partner to Co-Market Semaglutide Injection in India

0

Lupin Limited entered into a Licensing and Supply Agreement with Zydus Lifesciences Limited to expand access to innovative Semaglutide injection (15 mg/3 ml) in India. The therapy will be offered through a patient-friendly reusable pen device, improving convenience and adherence. The strategic collaboration combines Lupin’s strong domestic market presence with Zydus’ advanced research and development capabilities. Together, both companies aim to accelerate access to next-generation therapies for metabolic disorders, particularly diabetes and obesity.

Key Highlights of the Licensing Agreement

Under the terms of the agreement, Lupin will receive semi-exclusive rights to co-market Zydus’ semaglutide injection in India. The product will be sold under the brand names Semanext® and Livarise® (Lupin), while Zydus will continue marketing it under SEMAGLYN™, MASHEMA™, and ALTERME™. Additionally, Lupin will pay upfront licensing fees along with milestone-based payments tied to pre-defined commercial and regulatory achievements. This structure ensures a performance-driven partnership aligned with long-term growth.

Strengthening Diabetes and Cardio-Metabolic Portfolio

Nilesh Gupta highlighted its strategic importance. He emphasized that the collaboration reinforces Lupin’s commitment to advancing treatment options for cardio-metabolic diseases. He further noted that GLP-1 therapies are transforming global treatment standards. Therefore, this partnership not only strengthens Lupin’s diabetes portfolio but also helps address critical unmet patient needs across India.

Focus on Innovation and Patient Convenience

Sharing his perspective, Sharvil Patel underscored the company’s patient-centric approach. He stated that Zydus continues to focus on life-changing innovations that improve patient outcomes and quality of life. Importantly, the reusable pen device has been designed to simplify therapy administration, making it more user-friendly. As a result, patients can manage their treatment more effectively. Through this collaboration, Zydus aims to significantly broaden access to both the medication and its advanced delivery system.

Expanding Access to Advanced Therapies in India

Overall, the Lupin–Zydus partnership marks a significant step toward improving access to innovative GLP-1 therapies in India. As per the press release, by leveraging complementary strengths, both companies are well-positioned to enhance treatment outcomes and support healthcare providers in managing the growing burden of diabetes and obesity.

Advertisement

Newsletter

Subscribe to our FREE Newsletter & Stay Updated

Advertisement